Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03405285 · ClinicalTrials.gov registry record · NA

Connected Catheter Clinical Feasibility Study( CFS)

A NA study of Urinary Bladder, Neurogenic, sponsored by Spinal Singularity.

Completed
Registry status
NA
Development phase
5
Enrollment target
2
Study locations

NCT03405285 is a NA study of Urinary Bladder, Neurogenic that has completed, run by Spinal Singularity. The registered enrollment target is 5 participants, below the 71-participant average among 7 other Urinary Bladder, Neurogenic trials with a reported enrollment target (93% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03405285, a NA study of Urinary Bladder, Neurogenic, has completed, sponsored by Spinal Singularity.

COMPLETED
Registry status
NA
Development phase
5 participants
Enrollment target
2
Study locations

Study Summary

The objective of this study is to evaluate the safety and essential performance of the Connected Catheter System in males with neurogenic lower urinary tract dysfunction (NLUTD), both in an acute clinical setting, and during and extended period (up to 29 days) of home use.

Interventions

  • DEVICE Connected Catheter

Study Locations (2)

California

  • West Coast Urology, 11411 Brookshire Avenue, Suite 508 - Downey
  • Tri Valley Urology, 25495 Medical Center Dr., Suite 204 - Murrieta

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2018-02-28
Est. Completion 2018-06-30
Phase NA

Sponsor

Spinal Singularity

5 total trials

What the Registry Record Tells You About NCT03405285

The ClinicalTrials.gov registry entry for NCT03405285 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 71-participant average among 7 other Urinary Bladder, Neurogenic trials with a reported enrollment target (93% lower). The listed sponsor is Spinal Singularity, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Urinary Bladder, Neurogenic appearing as the primary indexed condition, and to 1 intervention - of which Connected Catheter is the first listed.

NCT03405285 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT03405285 about?

NCT03405285 is a clinical study titled "Connected Catheter Clinical Feasibility Study( CFS)". The objective of this study is to evaluate the safety and essential performance of the Connected Catheter System in males with neurogenic lower urinary tract dysfunction (NLUTD), both in an acute clinical setting, and during and extended period (up to 29 days) of home use.

What is the current status of trial NCT03405285?

This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2018-02-28. Estimated completion is 2018-06-30.

What conditions does trial NCT03405285 study?

This clinical trial studies the following conditions: Urinary Bladder, Neurogenic.

What interventions are being tested in trial NCT03405285?

The interventions under investigation include: Connected Catheter (DEVICE).

Who is sponsoring clinical trial NCT03405285?

This trial is sponsored by Spinal Singularity, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03405285 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Urinary Bladder, Neurogenic

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.